The new guidelines, published in the Journal of the American Academy of Dermatology (JAAD), will guide dermatologists in deciding the best possible prevention and treatment options for pediatric ...

Red, itchy, and scaly skin from atopic dermatitis and eczema can be uncomfortable, confusing, and all too familiar. These chronic (meaning they can last a long time) inflammatory conditions can appear ...

Most patients and doctors know that stress exacerbates AD. A new study pinpoints a neural mechanism that may be involved in ...

An international consensus group has endorsed formal definitions for atopic dermatitis disease activity and remission, part ...

Experts break down the most important facts about atopic dermatitis on the hands, including risk factors, treatments, and tips for soothing relief. Atopic dermatitis (AD), the most common form of ...

Add Yahoo as a preferred source to see more of our stories on Google. While eczema is a common skin condition, it can manifest in many different ways. And with so much possible variation, it's not ...

The American Academy of Dermatology (AAD) released 2 guidelines for the prevention of pediatric atopic dermatitis.

VTAMA was the only steroid-free topical AAD found supported by high certainty of evidence across all severities in children 2 years and older with AD.

Already FDA-approved for adults and children 12 years or older, researchers explore extending the nemolizumab age range down to 2 years in atopic dermatitis.

Patients with atopic dermatitis who receive treatment with dupilumab may be at an increased risk for new-onset vitiligo.

Higher maternal prepregnancy body mass index and birth length were associated with greater risk for atopic dermatitis by age 3 years.

The atopic dermatitis market presents strong opportunities due to a forecasted growth driven by seven upcoming late-stage drugs, expanding treatment options for all ages and severities, and innovative ...